AETOSBIO

AETOS BIOLOGICS is a California Corporation that was spun out from CELLTHEON CORPORATION in 2017... Celltheon was started in 2012 to develop the next generation Cell Line Development (CLD) technologies and platform for the development of biotherapeutics. The Celltheon SMART™ platform was built with an exhaustive approach to protein expression engineering, resulting in unprecedented consistency in producing high titer cell lines, regardless of protein complexity. 100+ novel molecules have been developed to date on the CELLTHEON SMART™ platform for clients. To further put its CLD technology to benchmark tests, Celltheon built a series of biosimilars using its platform... This is the home page's excerpt